Shield Therapeutics PLC signs Canada licence agreement for Accrufer with KYE Pharmaceuticals Inc.
Shield will receive up to £1mln in upfront, development and sales milestones
Source: proactiveinvestors.co.uk
Page 12 - Greg Madison News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Greg Madison. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Greg Madison Today - Breaking & Trending Today
Shield Therapeutics PLC rapidly expanding patient access for its iron deficiency product
Accrufer placed on formulary 1, a continually updated list of prescription drugs approved for reimbursement in the US
Source: proactiveinvestors.com
Shield Therapeutics PLC rapidly expanding patient access for its iron deficiency product
Accrufer placed on formulary 1, a continually updated list of prescription drugs approved for reimbursement in the US
Source: proactiveinvestors.co.uk
Shield Therapeutics shares fall as swings to loss in first half
Shield Therapeutics shares fall as swings to loss in first half | Financial News
Source: lse.co.uk
Shield Therapeutics' present drive for US launch success of iron deficiency product Accrufer
Shield Therapeutics PLC (LSE:STX, FRA:1JS) (LSE:STX) new CEO Greg Madison talks to Proactive London about his strategy for the company and focus on...
Source: proactiveinvestors.co.uk